Influence of Plasma Exchange Therapy on the Pharmacokinetics of Rituximab in Patients Treated for Autoimmune Disorders.
Phase of Trial: Phase IV
Latest Information Update: 17 May 2017
At a glance
- Drugs Rituximab (Primary)
- Indications Autoimmune disorders; Renal transplant rejection
- Focus Pharmacokinetics
- 09 Jul 2012 Last checked against European Clinical Trials Database record.
- 06 Mar 2010 Actual patient number (20) added as reported by ClinicalTrials.gov.
- 26 Aug 2009 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.